'It's like fauxtox!' The $66 face cream that women over 40 swear by
I can't really explain it, but you know that fresh smell you get when you leave a really good facial? Or the lingering scent of essential oils on your skin after a relaxing massage? That's what it smells like.
"It" being a new face cream I've been using and loving. And as it turns out, I'm not the only one.
Let's rewind a little.
Women over 40 - or even earlier for the really unlucky ones - have been speaking openly about perimenopausal symptoms affecting their everyday life more so than ever before. They're coming together in support, and even educating the clueless men in their lives about why we are sometimes so ragey about the way they're stacking the dishwasher.
Want to join the family? Sign up to our Kidspot newsletter for more stories like this.
Perimenopause symptoms suck
Yes, there's the mood and menstrual cycle changes, as well as hot flushes, irritability, mood swings, night sweats, sleep disruption, and changes in your libido.
But what about your skin? When discussing peri symptoms, no one seems to talk about how lifeless, blotchy, and puffy your skin can get.
According to my GP, I'm "not there yet" but that's certainly news to my face!
Ever since I hit 40, I've been blessed with the occasional outburst of adult acne, far too much pigmentation, and just general dullness. So when I heard that one of my favourite local brands had released a cream just for women approaching their menopause phase in life, you bet I wanted to give it a try.
And before you ask... NO, this isn't sponsored! I genuinely want to share it with you.
RELATED: The $52 moisturiser that banishes adult acne
Antipodes' Jasmine Flower face cream retails at $66. Image: Supplied
The $66 face cream for women approaching menopause
New Zealand skincare brand, Antipodes, recently launched their Jasmine Flower Menopause Facial Cream (RRP $66, 60ml) - a day cream that targets women who are suffering from visible symptoms of perimenopause and full-blown menopause.
It's silky, cooling, smells divine with the scent of jasmine (see notes above about the smell you get leaving a facial), and targets redness, fine lines and wrinkles.
When I applied the cream for the first time, I was a little worried about the thickness - it had the same consistency as a 50+ sunscreen. But within seconds of rubbing it in, the white cream soaks into your skin, leaving it super moisturised and your face full of life.
"Formulated for sensitive skin, it helps with visible signs of menopause such as redness, severe dehydration, hormonal blemishes, and signs of ageing, to smooth and balance your evolving complexion," the website description reads.
Born and bread in New Zealand... just for your peri skin needs. Image: Supplied
"Organic oat extract calms red, irritated, and sensitive skin. Peptides from chamomile and fermented jasmine flowers help relax lines and wrinkles. New Zealand avocado oil, with collagen boosting properties, fused with manuka honey to ease signs of ageing whilst reducing blemishes."
I caught a glimpse of myself in the mirror a few hours after applying, and my face not only felt great, it made me look alive again! The redness and puffiness I woke up with were gone, and I was left with a radiant base that really needed nothing on top.
It was like fauxtox in a jar!
RELATED: What you need to know about perimenopause
The women have spoken!
Before launching the day cream, the Antipodes team conducted an independent clinical study with 50 women suffering from sensitive skin.
After trialling it, 78% said the cream visibly calmed their irritated skin.
Jennie is just one of those women who has seen a visible improvement after consistently using the cream for three weeks.
"I have loved this product, it's not heavy but covers well and really left my skin feeling hydrated. I have three types of rosacea: in my eyes, the red skin one and papulopustular, and this cream has looked after all three," she praised.
Jennie suffered from a heap of skin issues, which the cream seemed to settle. Image: Supplied
Hanni also gave it a 5-star review, claiming she saw a "huge improvement" in her skin's moisture level.
"My skin blotches are disappearing after only two weeks," she confessed.
And the glowing (boom boom) reviews keep coming.
"The plumpness and reduced tightness are game changers... My combination skin feels perfectly balanced—no excess oil, just smooth and hydrated," a fan wrote online.
Another agreed: "This product is amazing - leaves your skin feeling and looking great. I'm sure my skin looked more youthful after using it. Love the scent too."
"Lovely and smooth, my skin loves it," another fan added.
Try it out for yourself! Grab a jar from Antipodesnature.com, Priceline, David Jones, Chemist Warehouse, Adore Beauty, Healthylife, Nourished Life as well as independent pharmacies and health shops across Australia.
Just don't expect it to calm your nerves around your annoying spouse.. that will still continue!
Originally published as 'It's like fauxtox!' The $66 face cream that women over 40 swear by
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News.com.au
4 hours ago
- News.com.au
‘Flabbergasted': Premier talks on-air to patient waiting 16 hours for western Sydney hospital bed
NSW Premier Chris Minns has been confronted live on-air by a patient who languished for 16 hours waiting for a bed at a western Sydney hospital. Jane was ordered to attend Concord Hospital by her GP about midday on Monday, but only received a bed in the emergency short-stay on Tuesday morning. Once in the ward, Jane said she was 'flabbergasted' to find two of the four beds were empty, with a nurse telling her they 'just don't have the staff to cover the beds'. 'So, all this time there's been empty beds, but they just don't have enough staff to monitor them,' Jane told 2GB's Ben Fordham on Tuesday. In the studio for the call, Mr Minns apologised to Jane for 'what would have been a very difficult night perched on those chairs in the ED'. 'I'm glad you've got a bed, but I don't want to be too cute about it,' he said. 'The reason everybody's sprung into action is because it's on the radio this morning. 'There's going to be a lot of people in New South Wales hospitals that don't have access to radio programs.' The Premier said the state government was trying to recruit and retain staff for emergency departments, and that there had been 'slow but steady improvement'. He said the number of patients in life-threatening states being seen on time had risen from 50 to 64 per cent because of the lifting of the wages cap. Mr Minns admitted the result was 'not where we need to be' and that with 6000-8000 people attending the ED every day, at points it 'gets completely overwhelmed'. 'It's really difficult,' he said, 'Now, I'm not suggesting that we are there, or it's been solved, or the solution has been found. 'There's going to be periods and times when people like Jane, who expect and not demand, but want the kind of help that they pay their taxes for are not going to receive. 'The reason I'm reluctant to sort of say, 'look, help you around the corner, Ben'... is that it's steady progress. 'It's going to take time to recruit people for the health system, get them into emergency departments and help people when they're in a really critical situation'. Jane was now waiting to see a surgical team. She told 2GB since appearing on-air, she had ben contacted by Health Minister Ryan Park and the executive director of Concord Hospital. It comes as the state government faces continued pressure of hospital conditions, particularly in western Sydney. Last month, a woman was forced to sleep in her car and an elderly man lied down under seats at Blacktown Hospital. Liverpool and Blacktown hospitals have consistently ranked 'significantly lower' than average in a survey of patient satisfaction, according to recent findings.
ABC News
5 hours ago
- ABC News
WA public hospitals reschedule elective surgeries after surge in demand
A number of planned elective surgeries have been put on hold in Western Australia due to a significant surge in demand on hospital emergency departments. In response to questions from the ABC, Health director general Dr Shirley Bowen said a high volume of patient presentations to WA's public hospitals overnight on Monday into Tuesday caused the surge. As a result, a number non-urgent surgeries planned for Wednesday in the metro area have been rescheduled. The postponement of elective surgeries is a strategy used by health authorities when the system is under pressure. In November 2021, widespread cancellations of non-urgent surgery across WA occurred during a strain on resources due to the COVID-19 pandemic. Dr Bowen said that was to ensure access to emergency healthcare for the rest of the week and impacted patients would be notified by their treating hospital. "To ensure access to emergency healthcare for Western Australians for the remainder of the week, WA Health is proactively rescheduling some non-urgent surgeries in the metropolitan area," Dr Bowen said. "We continue to prioritise our most seriously ill and injured patients. Dr Bowen acknowledged that the rescheduling might be "inconvenient and difficult for some patients". "We are committed to ensuring patients' surgery is re-scheduled as soon as possible."
News.com.au
6 hours ago
- News.com.au
‘Huge change': ASX falls as CSL announces new business plan
Australia's sharemarket snapped a six-day winning streak after pharmaceutical giant CSL had its worst day of trading on record after announcing a disappointing earnings update. The ASX 200 index dropped 63.10 points or 0.70 per cent to 8,896.20 while the broader All Ordinaries fell 59.70 points or 0.65 per cent to 9,173.80 The Australian dollar slipped 0.14 per cent to 64.85 US cents. Seven of the 11 sectors ended higher but a slump in the healthcare sector led to the market downturn. Healthcare stocks fell 8.73 per cent, led by CSL shares which slumped 16.89 to $225.50 its biggest ever one day fall, despite reporting underlying profits were up 14 per cent to $3.3bn. This was a fall of around $21bn in market cap. Shares plunged in the healthcare giant after it announced it would cut 3000 global roles costing $770m initially before helping the business save $500m-$550m over three years. CSL also announced its intention to demerge its influenza prevention vaccines-focused unit known as Seqirus into a separate ASX-listed business in 2026. It will also combine the commercial and medical operations of its core blood plasma and iron deficiency businesses into one unit. eToro market analyst Josh Gilbert said while the restructuring comes with a sizeable one off cost, the move is expected to sharpen the group's focus on its high-growth plasma and kidney care business. 'For investors, the view here is that CSL is trying to create a clearer business structure and improve investor returns. However, markets hate uncertainty, and this shake-up brings plenty of it,' he said. 'These are huge changes that come with execution risk, and in my view, the market will react poorly to the news short term.' Australia's second-biggest company BHP jumped 1.57 per cent to $42.12 after the business delivered its latest financial update. The company reported underlying profits of $US10.2bn ($A15.7bn), a 26 per cent fall compared with last year. Revenues came in at $US51.3bn ($A79bn), an 8 per cent fall in 2024. Despite falls in revenue and earnings, chief executive Mike Henry called the results 'a strong performance'. 'FY25 was another strong year for BHP, marked by record production, continued sector-leading margins and disciplined capital allocation,' he said. 'Safety remains our highest priority and we achieved year-on-year improvements across key metrics.' Shares in iron ore rivals Rio Tinto and Fortescue were down 0.22 and 0.15 per cent respectively. Financials were a brighter spot, with all four banks gaining. CBA added 0.51 per cent to $171.05, Westpac gained 0.65 per cent to $37.31, NAB jumped 0.77 per cent to $40.54 and ANZ finished 0.61 per cent higher to $32.77. In company news, Seek was one of strongest performers on the ASX 200 after it announced an increase in revenue despite fewer job ads, leading to a 7.99 per cent bounce to $27.72. Australia's largest manufacturer and distributor of 4x4 accessories ARB shares marched 8.55 per cent higher to $39.49 after the business told the market sales revenue was up 5.3 per cent to $729.9m, while net profits after tax were down 5 per cent to $97.5m. Judo Capital also eked out a gain of 0.29 per cent to $1.75 after full-year profits were up 24 per cent to $86.4m, on the back of a lift to its all important net interest margin. Reliance Worldwide shares fell 6.74 per cent to $4.29 despite the business announcing sales were up 5.5 per cent and reported net earnings after tax jumped 13.5 per cent to $US125m ($192m).
